Iguchi Toshihiro, Inaba Yoshitaka, Arai Yasuaki, Yamaura Hidekazu, Sato Yozo, Miyazaki Masaya, Shimamoto Hiroshi, Hayashi Takayuki
Department of Interventional and Diagnostic Radiology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan.
AJR Am J Roentgenol. 2006 Dec;187(6):1579-84. doi: 10.2214/AJR.05.0646.
The purpose of our study was to retrospectively evaluate the safety and efficacy of radiologic removal and replacement of port-catheter systems.
Between January 1999 and December 2004, 532 patients with unresectable advanced liver cancer underwent radiologic placement of port-catheter systems at our institution. Of these, 18 patients (nine men and nine women; age range, 32-83 years; mean age, 53.8 years) underwent removal of an implanted port-catheter system via the right femoral artery and radiographically guided replacement with a new system to allow continuous hepatic arterial infusion chemotherapy; we retrospectively reviewed these 18 cases. The reasons for removal of the previously implanted systems were as follows: catheter dislodgement (n = 15), catheter obstruction (n = 1), infection related to the implanted port (n = 1), and hemodynamic change (n = 1). Digital subtraction angiography and CT were performed, usually during injection of contrast medium through the implanted port-catheter system, within a few days after the replacement procedure and every 3 months thereafter.
We successfully performed radiologic removal and replacement of the portcatheter system while the patient was under local anesthesia in all 18 patients without complications requiring treatment. The cumulative patency rates of the hepatic artery after removal of the old port-catheter system and replacement with a new port-catheter system were 87.8% and 64.1% at 6 months and 1 year, respectively. Hepatic arterial infusion chemotherapy after replacement was performed 0-68 times (median, 19 times).
When an implanted port-catheter system can no longer be used but the patency of the hepatic artery is confirmed and continuous hepatic arterial infusion chemotherapy is required, removal and replacement of the port-catheter system are recommended.
本研究的目的是回顾性评估经放射学方法取出和更换端口导管系统的安全性和有效性。
1999年1月至2004年12月期间,532例不可切除的晚期肝癌患者在我院接受了端口导管系统的放射学植入。其中,18例患者(9例男性和9例女性;年龄范围32 - 83岁;平均年龄53.8岁)通过右股动脉取出植入的端口导管系统,并在放射学引导下用新系统进行更换,以允许持续肝动脉灌注化疗;我们回顾性分析了这18例病例。取出先前植入系统的原因如下:导管移位(n = 15)、导管阻塞(n = 1)、与植入端口相关的感染(n = 1)和血流动力学改变(n = 1)。在更换手术后几天内以及此后每3个月,通常在通过植入的端口导管系统注射造影剂期间进行数字减影血管造影和CT检查。
在所有18例患者中,我们均在局部麻醉下成功进行了端口导管系统的放射学取出和更换,且无需要治疗的并发症。取出旧的端口导管系统并更换新的端口导管系统后,肝动脉的累积通畅率在6个月和1年时分别为87.8%和64.1%。更换后进行肝动脉灌注化疗0 - 68次(中位数,19次)。
当植入的端口导管系统无法再使用,但肝动脉通畅且需要持续肝动脉灌注化疗时,建议取出并更换端口导管系统。